Diabetic foot ulcer is a major complication of diabetes mellitus, and probably the major component of the diabetic foot. It occurs in 15% of all patients with diabetes and precedes 84% of all lower leg amputations. Major increase in mortality among diabetic patients, observed over the past 20 years is considered to be due to the development of macro and micro vascular complications, including failure of the wound healing process. Wound healing is a ‘make-up’ phenomenon for the portion of tissue that gets destroyed in any open or closed injury to the skin. Being a natural phenomenon, wound healing is usually taken care of by the body’s innate mechanism of action that works reliably most of the time. Key feature of wound healing is stepwise repair of lost extracellular matrix (ECM) that forms largest component of dermal skin layer. Therefore controlled and accurate rebuilding becomes essential to avoid under or over healing that may lead to various abnormalities. But in some cases, certain disorders or physiological insult disturbs wound healing process that otherwise goes very smoothly in an orderly manner. Diabetes mellitus is one such metabolic disorder that impedes normal steps of wound healing process. Many histopathological studies show prolonged inflammatory phase in diabetic wounds, which causes delay in the formation of mature granulation tissue and a parallel reduction in wound tensile strength.
Non-healing chronic diabetic ulcers are often treated with extracellular matrix replacement therapy. So far, it is a common trend in diabetic foot care domain to use advanced moist wound therapy, bio-engineered tissue or skin substitute, growth factors and negative pressure wound therapy. No therapy is completely perfect as each type suffers from its own disadvantages. Moist wound therapy is known to promote fibroblast and keratinocyte proliferation and migration, collagen synthesis, early angiogenesis and wound contraction. At present, there are various categories of moist dressings available such as adhesive backing film, silicone coated foam, hydrogels, hydrocolloids etc. Unfortunately, all moist dressings cause fluid retention; most of them require secondary dressing and hence are not the best choice for exudative wounds. To address the physiological deficiencies underlying diabetic ulcer, various tissue engineering technologies have come up with cellular as well as acellular skin replacement products.
Other articles related to "diabetic, foot, diabetics, diabetic foot ulcer, diabetic foot, ulcer, foot ulcers":
... It has been shown to ameliorate some diabetic complications, such as neuropathy and microvascular damage ... A small area of skin, usually on the foot, that has become thick and hard from rubbing or pressure as a result of increased production of surface skin (i.e ... Calluses are important risk factors for diabetics, in part because of changes in skin or vasculature characteristic of feet and lower legs in diabetics ...
... Identification of diabetic foot in medical databases, such as commercial claims and prescription data, is complicated by the lack of a specific ICD-9 code for diabetic ... The following codes indicate ulcer of the lower limb or foot 707.1 Ulcer of lower limbs, except pressure ulcer 707.14 Ulcer of heel and midfoot 707.15 Ulcer of other ... only one diagnostic code (ICD-9-CM 707.1×, "Ulcer of lower limbs, except decubitus"), in a study of incidence rates and treatment costs of foot ulcers among individuals ...
Famous quotes containing the word foot:
“Usually the scenery about them is drear and savage enough; and the loggers camp is as completely in the woods as a fungus at the foot of a pine in a swamp; no outlook but to the sky overhead; no more clearing than is made by cutting down the trees of which it is built, and those which are necessary for fuel.”
—Henry David Thoreau (18171862)